Results 101 to 110 of about 119,526 (169)

Development of pemphigus vulgaris in a patient with vitiligo and Hashimoto's thyroiditis

, 2005
Pemphigus vulgaris is an autoimmune blistering disease. An association of pemphigus vulgaris with vitiligo or Hashimoto's thyroiditis has not been reported before.
Öztas, PINAR, Toy, G.G., Tamer, E., Alli, N., Yalçin, B.   +4 more
core   +1 more source

Clinical and biochemical changes during high-dose glucocorticoid therapy in patients with pemphigus vulgaris (a comparative study with endogenous hypercortisolism)

Alʹmanah Kliničeskoj Mediciny
Background: Pemphigus vulgaris is an autoimmune bullous dermatosis for which high-dose glucocorticoid (GC) therapy is the first-line treatment. However, the use of supraphysiological GC doses may lead to the development of hypercortisolism symptoms ...
Nataliia A. Budul, Vladislava O. Kornushenko, Irina V. Komerdus, Anton V. Molochkov, Oleg V. Karzanov, Yulia A. Dodrovolnaya, Irena A. Ilovayskaya   +6 more
doaj   +1 more source

CEFACLOR INDUCED PEMPHIGUS VULGARIS

, 2004
Pemphigus is a chronic disease with an outcome that is not without risk. It is characterised by loss of the intraepithelial cell-cell relationship (acantholysis).
MESSINA, Pietro, CONTI NM, SCARDINA, Giuseppe Alessandro   +2 more
core  

Conjoint analysis of methylation, transcriptomic, and proteomic profiles in pemphigus vulgaris

Orphanet Journal of Rare Diseases
Background The underlying pathogenesis of pemphigus vulgaris, an autoimmune skin disorder, remains incompletely understood. An integrative analysis comprising DNA methylation, mRNA expression, and proteomic data in patients with pemphigus vulgaris was ...
Xiaojia Luo, Jianting Ouyang, Fuqiong Jiang, Yaozhong Zhang, Yuan Wang, Yongzhuo Wu, Lingyu Hu   +6 more
doaj   +1 more source

Rilzabrutinib-induced transition from pemphigus vulgaris to pemphigus foliaceous: case report and review of the literature

Dermatology Reports
The discovery of the role of Bruton’s Tyrosine Kinase (BTK) in inflammation and autoimmunity has recently led to the development of BTK inhibitors for the treatment of autoimmune diseases, including pemphigus vulgaris.
Christian Ciolfi, Jacopo Tartaglia, Francesca Pampaloni, Laura Fagotto, Andrea Sechi, Mauro Alaibac   +5 more
doaj  

CORRELATION OF PEMPHIGUS VULGARIS ANTIBODY TITERS BY INDIRECT IMMUNOFLUORESCENCE WITH ACTIVITY OF DISEASE BASED ON PEMPHIGUS AREA AND ACTIVITY SCORE (PAAS)

Acta Medica Iranica, 2008
Indirect immunofluorescence (IIF) has been used to identify and measure autoantibody levels in pemphigus vulgaris but data about relationship between clinical severity of disease and antibody titers by IIF have been conflicting.
H. Mortazavi, K. Kiavash, N. Esmaili C. Chams-Davatchi   +2 more
doaj  

Pemphigus vulgaris [PDF]

QJM: An International Journal of Medicine, 2017
T, Chaubal, R, Bapat, P, Wadkar
openaire   +2 more sources

Artificial Intelligence (AI) in the Identification of Pemphigus Vulgaris as Compared with Healthy Mucosa Using Clinical Images: A Retrospective Study

Journal of Indian Academy of Oral Medicine and Radiology
Background: Pemphigus is a chronic autoimmune inflammatory condition characterized by the formation of blisters and ulcers on mucous membranes and skin. Proper diagnosis is essential for managing the disease.
Turaga Amani, A Hari Priya, S Sowmya
doaj   +1 more source

Pemphigus vulgaris [PDF]

BMJ, 2007
openaire   +2 more sources

Mucocutaneous pemphigus vulgaris carrying high-titre antidesmoglein 1 antibodies with skin lesions resembling pemphigus erythematosus

, 2008
Patients with pemphigus vulgaris (PV) who have both antidesmoglein (Dsg)1 and anti-Dsg3 antibodies usually develop flaccid blisters on skin and mucous membranes.
CIRILLO N, LANZA, Alessandro, ANNESE P, LANZA, Michele, GOMBOS F, SANTORO, Rossella   +5 more
core   +1 more source